A growing body of evidence indicated that NAFLD is accompanied with downregulated CYP450 expression, enhanced sEH activity and reduced EETs concentration [144], suggesting the crucial roles of AA-CYP450-EETs-sEH in pathophysiology of NAFLD. Here, EPHX2 is linked to metabolic dysfunction-associated steatotic liver disease.